These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25222248)

  • 1. Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer.
    Chen ZH; Wang L; Luo LP
    Genet Mol Res; 2014 Sep; 13(3):7484-91. PubMed ID: 25222248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer in a Chinese population.
    Li J; Zuo X; Lv X; Kong F; Xu W; Yang S
    Tumour Biol; 2014 Aug; 35(8):7569-74. PubMed ID: 24793015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy.
    Lu ZM; Luo TH; Nie MM; Fang GE; Ma LY; Xue XC; Wei G; Ke CW; Bi JW
    Tumour Biol; 2014 Apr; 35(4):2941-8. PubMed ID: 24318989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer.
    Yu H; Wu X; Zhang Y; Jin Z; Li G; Zhao H
    Int J Clin Exp Pathol; 2015; 8(4):4106-12. PubMed ID: 26097599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population.
    Yang Z; Fang X; Pei X; Li H
    Genet Test Mol Biomarkers; 2013 Sep; 17(9):700-6. PubMed ID: 23909490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in ERCC1 and XPF gene and response to chemotherapy and overall survival of non-small cell lung cancer.
    Shi ZH; Shi GY; Liu LG
    Int J Clin Exp Pathol; 2015; 8(3):3132-7. PubMed ID: 26045829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer.
    Liu L; Li CH; Jin TF; Xu DY
    Genet Mol Res; 2014 Oct; 13(4):8722-8. PubMed ID: 25366763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
    Mo J; Luo M; Cui J; Zhou S
    Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients.
    Zhong G; Li HK; Shan T; Zhang N
    Genet Mol Res; 2015 Dec; 14(4):17228-34. PubMed ID: 26681216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer.
    Zhou J; Liu ZY; Li CB; Gao S; Ding LH; Wu XL; Wang ZY
    Tumour Biol; 2015 Apr; 36(4):3017-23. PubMed ID: 25542228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
    Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
    Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ERCC1 polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer.
    Gao H; Ge RC; Liu HY; Wang Y; Yan S
    Genet Mol Res; 2014 Oct; 13(4):8997-9004. PubMed ID: 25366790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
    Sun Y; Wu Y; Li W; Kong Z; Zou X
    Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer.
    Yu WH; Wang YX; Guo JQ; Wang YL; Zheng JS; Zhu KX
    Genet Mol Res; 2015 Dec; 14(4):17529-35. PubMed ID: 26782397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variability of ERCC1 genes in NER pathway influences the treatment outcome of gastric cancer.
    Bai Y; Wang L; Li G; Fang X; Li Y; Yang S
    Int J Clin Exp Pathol; 2015; 8(10):13367-73. PubMed ID: 26722542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population.
    He J; Xu Y; Qiu LX; Li J; Zhou XY; Sun MH; Wang JC; Yang YJ; Jin L; Wei QY; Wang Y
    PLoS One; 2012; 7(11):e49308. PubMed ID: 23166636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excision repair cross-complementation group 1 codon 118 polymorphism, micro ribonucleic acid and protein expression, clinical outcome of the advanced gastric cancer response to first-line FOLFOX-4 in Qinghai-Tibetan plateau population.
    Qi YJ; Cui S; Yang YZ; Han JQ; Cai BJ; Sheng CF; Ma Y; Wuren T; Ge RL
    J Cancer Res Ther; 2013; 9(3):410-5. PubMed ID: 24125975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variability of ERCC1 and ERCC2 genes involved in the nucleotide excision repair pathway influences the treatment outcome of gastric cancer.
    Zheng DL; Tang GD; Chen YN; Zhang T; Qin MB
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERCC1 gene +262A/C polymorphism associated with risk of gastric cardiac adenocarcinoma in nonsmokers.
    Zhou RM; Niu CX; Wang N; Chen ZF; Lei SE; Li Y
    Arch Med Res; 2012 Jan; 43(1):67-74. PubMed ID: 22374244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.